Hormone therapy resistance and the ensuing aggressive tumor progression present a significant clinical challenge. However, the mechanisms underlying the induction of tumor malignancy upon inhibition ...

Unbeknownst to many, enduring acid reflux for an extended period can increase the risk of developing Barrett's oesophagus, which has the potential to progress into oesophageal cancer — a cancer ...

TIL therapy uses a patient's own T cells, expanded in vitro, to target cancer cells, offering a personalized treatment approach. Amtagvi (lifileucel) is the first FDA-approved TIL therapy for advanced ...

The eye gi­ant Al­con has launched an un­like­ly le­gal bat­tle, su­ing a cell ther­a­py start­up that it in­vest­ed in and claim­ing its share­hold­er rights are … ...

New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has revealed how it interacts with genes to interrupt cell growth signals.

In a recent Science article, researchers unveiled a method to kill cancer cells by sticking two proteins together to activate a gene that signals for cell death. This new method is helpful for ...

When foam cells are in a tumor environment, this also activates mechanisms that make tumors more aggressive and worsen prospects for survival. They begin to release signal substances that ...

Carvykti followed Bristol Myers Squibb and 2Seventy bio’s Abecma onto the market. Like Abecma, it is a CAR-T therapy targeted to a protein called BCMA that’s commonly found on diseased multiple ...